Pyrotinib Maleate single box price and purchase channels
Pyrotinib (Pyrotinib Maleate) is a targeted therapy drug mainly used to treat HER2 positive breast cancer, especially for patients who are ineffective or resistant to traditional treatments. As an innovative drug, the efficacy of pyrotinib has been verified in multiple clinical studies and has been independently developed and launched in the domestic market.
The main function of pyrotinib is to block the proliferation of cancer cells by inhibiting the HER2 receptor, thereby inhibiting the growth of tumors. Pyrotinib offers a new treatment option for patients with HER2-positive breast cancer, especially those who have progressed despite chemotherapy or other anti-HER2 drugs. Compared with traditional treatment methods, pyrotinib has a strong anti-tumor effect and can effectively improve patients' survival and quality of life.
In addition to treating HER2 positive breast cancer, pyrotinib is also being explored for use in other cancer types. Research shows that pyrotinib may have a certain effect on other HER2 positive tumors such as gastric cancer, which makes it show broad prospects in the field of cancer treatment.
As for price, the price of a single box of pyrotinib in the domestic market is generally between 2000-4000 RMB. Since pyrotinib has been included in the scope of medical insurance, some patients may be able to obtain certain price discounts after being reimbursed by medical insurance. The specific price will vary depending on the region, hospital and medical insurance policy, so patients should consult the local hospital or pharmacy for detailed prices when purchasing.
At present, the original drug of pyrotinib has been launched in China, but there are no generic drugs on the market yet. Therefore, patients can only purchase the drug through formal channels. Patients can prescribe medicines in hospitals, purchase them in pharmacies, or purchase them through medicine suppliers. However, when purchasing, they must ensure that the medicines come from regular sources and avoid buying counterfeit and shoddy medicines.
Reference materials: https://www.drugs.com
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)